PM · Philip Morris International Inc. · Financials
Market Cap
$289.45B
Shares
1.56B
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$40.65B
+7.3%
FY2025
Net Income
$11.35B
+60.8%
FY2025
Gross Margin
67.12%
+2.3pp
FY2025
Operating Margin
36.64%
+1.3pp
FY2025
Diluted EPS
$7.26
+60.6%
FY2025
Operating Cash Flow
$12.23B
+0.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $42.55B | $40.65B | $37.88B | $35.17B | $31.76B | $31.41B | $28.69B | $29.81B | $29.63B | $28.75B | $26.69B | $73.91B | $80.11B | $80.03B | $77.39B | $76.35B | $67.71B | $62.08B | $63.64B | $55.24B | |
| — | -$1.13B | — | — | -$1.06B | -$588M | -$628M | -$618M | -$570M | -$665M | -$914M | -$891M | -$1.01B | -$1.05B | -$973M | -$859M | -$800M | -$876M | -$797M | -$311M | -$10M | |
| — | $13.84B | $13.37B | $13.33B | $12.89B | $11.4B | $10.03B | $9.57B | $10.51B | $10.76B | $10.43B | $9.39B | $9.37B | $10.44B | $10.41B | $10.37B | $10.68B | $9.71B | $9.02B | $9.33B | $8.71B | |
| — | $28.71B | $27.28B | $24.55B | $22.28B | $20.36B | $21.38B | $19.13B | $19.29B | $18.87B | $18.32B | $17.29B | $17.43B | $19.33B | $20.81B | $21B | $20.42B | $17.5B | $16.01B | $16.38B | $14.1B | |
| — | — | 67.12% | 64.81% | 63.35% | 64.1% | 68.06% | 66.65% | 64.73% | 63.69% | 63.71% | 64.81% | 23.58% | 24.13% | 26% | 27.14% | 26.75% | 25.84% | 25.79% | 25.73% | 25.52% | |
| — | — | $756M | $759M | $709M | $642M | $617M | $495M | $465M | $383M | $453M | $429M | $423M | $433M | $449M | $415M | $413M | $391M | $335M | $334M | — | |
| — | — | — | — | — | — | — | — | — | — | $164M | $161M | $162M | $165M | $187M | $210M | — | — | — | — | — | |
| — | $1.01B | $1B | $835M | $497M | — | $96M | $73M | $66M | $82M | $88M | $74M | $82M | $93M | $93M | $97M | $98M | $88M | $74M | $44M | $28M | |
| — | $2.05B | $2B | $1.79B | $1.4B | $1.08B | $998M | $981M | $964M | $989M | $875M | $743M | $754M | $889M | $882M | $898M | $993M | $932M | $853M | $842M | $748M | |
| — | $23M | $149M | $77M | $78M | $0 | $216M | $141M | — | — | — | $0 | $68M | $391M | $309M | $55M | -$75M | — | — | — | — | |
| — | $16.06B | $14.89B | $13.4B | $11.56B | $12.25B | $12.98B | $11.67B | $10.53B | $11.38B | $11.58B | $10.9B | $10.62B | $11.7B | $13.52B | $13.86B | $13.34B | $11.2B | $10.04B | $10.25B | $8.89B | |
| — | — | 36.64% | 35.38% | 32.85% | 38.56% | 41.32% | 40.66% | 35.33% | 38.4% | 40.28% | 40.86% | 14.37% | 14.61% | 16.89% | 17.91% | 17.48% | 16.54% | 16.17% | 16.1% | 16.1% | |
| — | $18.11B | $16.89B | $15.19B | $12.95B | $13.32B | $13.97B | $12.65B | $11.5B | $12.37B | $12.46B | $11.65B | $11.38B | $12.59B | $14.4B | $14.76B | $14.34B | $12.13B | $10.89B | $11.09B | $9.64B | |
| — | — | $1.59B | $1.76B | $1.53B | $768M | $737M | $728M | $796M | $855M | $1.1B | $1.07B | $1.13B | $1.17B | $1.1B | $1.01B | $934M | $974M | $905M | $528M | — | |
| — | — | $621M | $620M | $465M | $180M | $109M | $110M | $226M | $190M | $182M | $178M | $124M | $118M | $131M | $148M | $134M | $98M | $108M | $217M | — | |
| — | -$120M | $705M | $637M | $157M | $137M | $149M | — | — | — | $59M | $94M | $105M | $105M | -$22M | -$17M | -$10M | — | — | — | — | |
| — | $15.12B | $13.88B | $12.2B | $10.45B | $11.63B | $12.23B | $10.95B | $9.87B | $10.67B | $10.59B | $9.92B | $9.62B | $10.65B | $12.54B | $13B | $12.54B | $10.32B | $9.24B | $9.94B | — | |
| — | $3.06B | $2.74B | $3.02B | $2.34B | $2.24B | $2.67B | $2.38B | $2.29B | $2.45B | $4.31B | $2.77B | $2.69B | $3.1B | $3.67B | $3.83B | $3.65B | $2.83B | $2.69B | $2.79B | $2.57B | |
| — | $10.87B | $11.35B | $7.06B | $7.81B | $9.05B | $9.11B | $8.06B | $7.19B | $7.91B | $6.04B | $6.97B | $6.87B | $7.49B | $8.58B | $8.8B | $8.59B | $7.26B | $6.34B | $6.89B | $6.04B | |
| — | — | 27.92% | 18.63% | 22.21% | 28.49% | 29% | 28.08% | 24.11% | 26.7% | 20.99% | 26.11% | 9.3% | 9.35% | 10.72% | 11.37% | 11.25% | 10.72% | 10.22% | 10.83% | 10.93% | |
| — | $556M | $500M | $446M | $455M | $479M | $601M | $536M | $543M | $375M | $306M | $283M | $159M | $165M | $274M | $354M | $288M | $239M | $210M | $260M | $276M | |
| — | $10.84B | $11.32B | $7.03B | $7.79B | $9.02B | $9.08B | $8.04B | $7.17B | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $12.37B | $10.37B | $7.56B | $5.56B | $9.07B | $10.71B | $6.24B | $7.93B | $6.34B | $7.06B | $6.81B | $4.3B | $4.86B | $7.99B | $8.06B | $6.87B | $6.94B | — | — | — | |
| USD/shares | — | $6.96 | $7.27 | $4.53 | $5.02 | $5.82 | $5.83 | $5.16 | $4.61 | $5.08 | $3.88 | $4.48 | $4.42 | $4.76 | $5.26 | $5.17 | $4.85 | $3.93 | $3.25 | $3.32 | $2.86 |
| USD/shares | $7.19 – $7.34 | $6.95 | $7.26 | $4.52 | $5.02 | $5.81 | $5.83G | $5.16 | $4.61 | $5.08 | $3.88 | $4.48 | $4.42 | $4.76 | $5.26 | $5.17 | $4.85 | $3.92 | $3.24 | $3.31 | $2.86 |
| shares | — | — | 1.56B | 1.55B | 1.55B | 1.55B | 1.56B | 1.56B | 1.56B | 1.56B | 1.55B | 1.55B | 1.55B | 1.57B | 1.62B | 1.69B | 1.76B | 1.84B | 1.94B | 2.07B | — |
| shares | — | — | 1.56B | 1.56B | 1.55B | 1.55B | 1.56B | 1.56B | 1.56B | 1.56B | 1.55B | 1.55B | 1.55B | 1.57B | 1.62B | 1.69B | 1.76B | 1.84B | 1.95B | 2.08B | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2007–FY2025: $38.64B in buybacks, $113.49B in dividends.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
7.82×
Tobacco median 1.77×
EV/EBIT
20.71×
Tobacco median 12.36×
P/E (TTM)
26.72×
Tobacco median 14.30×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Europe Segment | $17,111,000,000 | $15,690,000,000 | $14,537,000,000 | $12,972,000,000 | $13,155,000,000 | — | — |
| SSEA CIS MEA Segment | $12,051,000,000 | $11,261,000,000 | $10,629,000,000 | $10,467,000,000 | $9,858,000,000 | — | — |
| EAAUPMIGTR Segment | $6,632,000,000 | $6,393,000,000 | $6,201,000,000 | — | — | — | — |
| Americas Segment | $4,854,000,000 | $4,534,000,000 | $3,807,000,000 | $2,116,000,000 | $1,843,000,000 | $1,701,000,000 | $2,206,000,000 |
| EAAUPMIDF Segment | — | — | — | $5,936,000,000 | $6,448,000,000 | — | — |
| East Asia and Australia Segment | — | — | — | — | — | $5,429,000,000 | $5,364,000,000 |
| Eastern Europe Segment | — | — | — | — | — | $3,378,000,000 | $3,282,000,000 |
| European Union Segment | — | — | — | — | — | $10,702,000,000 | $9,817,000,000 |
| Middle East and Africa Segment | — | — | — | — | — | $3,088,000,000 | $4,042,000,000 |
| South and Southeast Asia Segment | — | — | — | — | — | $4,396,000,000 | $5,094,000,000 |
| Swedish Match AB | — | — | — | — | — | $0 | — |
| Swedish Match AB Segment | — | — | — | — | $0 | — | — |
| Wellness and Healthcare | — | — | — | — | — | $0 | — |
| Wellness and Healthcare Segment | — | — | — | $271,000,000 | $101,000,000 | — | — |
| All Other Segments | — | — | — | — | — | — | $0 |
By Geography (USD)
| Component | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Saudi Arabia | -$246,000,000 | — | — | — | — |
| East Asia and Australia | — | $5,429,000,000 | $5,364,000,000 | $5,580,000,000 | $6,373,000,000 |
| Eastern Europe | — | $3,378,000,000 | $3,282,000,000 | $2,921,000,000 | $2,711,000,000 |
| Latin America and Canada | — | $1,701,000,000 | $2,206,000,000 | $3,056,000,000 | $2,941,000,000 |
| Middle East and Africa | — | $3,088,000,000 | $4,042,000,000 | $4,114,000,000 | $3,988,000,000 |
| South and Southeast Asia | — | $4,396,000,000 | $5,094,000,000 | $4,656,000,000 | $4,417,000,000 |
| European Union | — | $10,702,000,000 | $9,817,000,000 | $9,298,000,000 | $8,318,000,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Combustible Tobacco Products | $23,794,000,000 | $23,218,000,000 | $22,334,000,000 | $21,572,000,000 | $22,067,000,000 | — | — | — |
| Smoke Free Products | $16,854,000,000 | $14,660,000,000 | $12,840,000,000 | $10,190,000,000 | $9,338,000,000 | $6,947,000,000 | — | — |
| Combustible Products | — | — | — | — | — | $21,747,000,000 | $24,218,000,000 | $25,529,000,000 |
| Reduced Risk Products | — | — | — | — | — | — | $5,587,000,000 | $4,096,000,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Europe Segment | $7,165,000,000 | $6,547,000,000 | $5,299,000,000 | $5,776,000,000 | $6,409,000,000 | — | — |
| SSEA CIS MEA Segment | $4,096,000,000 | $3,429,000,000 | $3,136,000,000 | $3,864,000,000 | $3,295,000,000 | — | — |
| EAAUPMIGTR Segment | $3,126,000,000 | $2,878,000,000 | $2,539,000,000 | — | — | — | — |
| Americas Segment | $505,000,000 | $548,000,000 | $582,000,000 | $440,000,000 | $487,000,000 | $564,000,000 | $235,000,000 |
| EAAUPMIDF Segment | — | — | — | $2,424,000,000 | $2,836,000,000 | — | — |
| East Asia and Australia Segment | — | — | — | — | — | $2,400,000,000 | $1,932,000,000 |
| Eastern Europe Segment | — | — | — | — | — | $871,000,000 | $547,000,000 |
| European Union Segment | — | — | — | — | — | $5,098,000,000 | $3,970,000,000 |
| Middle East and Africa Segment | — | — | — | — | — | $1,026,000,000 | $1,684,000,000 |
| South and Southeast Asia Segment | — | — | — | — | — | $1,709,000,000 | $2,163,000,000 |
| Swedish Match AB | — | — | — | — | — | $0 | — |
| Swedish Match AB Segment | — | — | — | — | $0 | — | — |
| Wellness and Healthcare | — | — | — | — | — | $0 | — |
| Wellness and Healthcare Segment | — | — | — | -$258,000,000 | -$52,000,000 | — | — |
| All Other Segments | — | — | — | — | — | — | $0 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Europe Segment | 41.9% | 41.7% | 36.5% | 44.5% | 48.7% | — | — |
| SSEA CIS MEA Segment | 34% | 30.5% | 29.5% | 36.9% | 33.4% | — | — |
| EAAUPMIGTR Segment | 47.1% | 45% | 40.9% | — | — | — | — |
| Americas Segment | 10.4% | 12.1% | 15.3% | 20.8% | 26.4% | 33.2% | 10.7% |
| EAAUPMIDF Segment | — | — | — | 40.8% | 44% | — | — |
| East Asia and Australia Segment | — | — | — | — | — | 44.2% | 36% |
| Eastern Europe Segment | — | — | — | — | — | 25.8% | 16.7% |
| European Union Segment | — | — | — | — | — | 47.6% | 40.4% |
| Middle East and Africa Segment | — | — | — | — | — | 33.2% | 41.7% |
| South and Southeast Asia Segment | — | — | — | — | — | 38.9% | 42.5% |
| Wellness and Healthcare Segment | — | — | — | -95.2% | -51.5% | — | — |
Key facts
CIK
1413329
CUSIP
718172109
13F (30d)
934 filings
903 filers
Visit website
Investor relations